It has been described that using noninvasive exposure to 40-Hz white light LED reduces
amyloid-beta, a peptide thought to initiate neurotoxic events in Alzheimer's disease (AD) …

Photobiomodulation therapy has become the focus of medical research in many areas such
as Alzheimer's disease (AD), because of its modulatory effect on cellular processes through …

Background Low-intensity light can decelerate neurodegenerative disease progression and
reduce amyloid β (Aβ) levels in the cortex, though the cellular and molecular mechanisms by …

Beta amyloid (Aβ) is well accepted to play a central role in the pathogenesis of Alzheimer's
disease (AD). The present work evaluated the therapeutic effects of low-level laser …

Mitochondrial dysfunction is a hallmark of amyloid β peptide (Aβ)-induced neuronal toxicity
in Alzheimer's disease (AD). However, the underlying mechanism (s) of Aβ-induced …

Oligomeric amyloid-β 1–42 (Aβ1–42) has a close correlation with neurodegenerative
disorder especially Alzheimer's disease (AD). It induces oxidative stress and mitochondrial …

Neurodegeneration is a complex process involving different cell types and
neurotransmitters. A common characteristic of neurodegenerative disorders is the …

Melatonin has a potential therapeutic value in Alzheimer's disease (AD), a disease that is
associated with a dramatic decline in memory and cognitive abilities. The aggregation of the …

Compromised cellular energy metabolism, cerebral hypoperfusion, and neuronal calcium
dysregulation are involved in the pathological process of Alzheimer's disease (AD). ATP …

Parkinson's disease is a common progressive neurodegenerative disorder characterized by
the degeneration of dopaminergic neurons in the substantia nigra pars compacta …